Shifting the treatment paradigm in idiopathic overactive bladder.

International Journal of Clinical Practice
Arun SahaiDudley Robinson

Abstract

Overactive Bladder (OAB) is a common condition that is known to have a significant impact on Health Related Quality of Life (HRQoL). Whilst all patients will initially benefit from lifestyle modifications and behavioural therapy in the first instance drug therapy remains integral in management pathways. The purpose of this review paper is to reappraise the evidence based approach to the management of OAB in addition to exploring a new treatment algorithm for the escalation of treatment in those patients with refractory symptoms. Literature Review RESULTS: Antimuscarinic drugs are currently the most commonly used medication although the introduction of mirabegron, a β3 agonist, has provided an alternative and also allowed combination therapy in those patients who have failed to improve on primary therapy or who have troublesome side effects. For those patients with symptoms of refractory OAB more invasive therapies including OnabotulinumtoxinA, sacral neuromodulation and Percutaneous Tibial Nerve Stimulation (PTNS) may be indicated. We propose a new, evidence based, treatment algorithm for the management of OAB in patients who remain refractory to first line therapy.

References

Jun 18, 2003·World Journal of Urology·W F StewartA J Wein
Jan 13, 2006·The Journal of Urology·H Hashim, P Abrams
Mar 13, 2009·BJU International·Debra E IrwinCon Kelleher
Nov 17, 2009·BJU International·Joshua S BennerLinda Brubaker
Nov 17, 2009·The Journal of Urology·Scott A MacDiarmidBrian A Feagins
Mar 6, 2010·International Journal of Clinical Practice·P E V Van KerrebroeckZ Guan
Jun 1, 2009·Therapeutic Advances in Urology·Karl-Erik Andersson
Jan 27, 2015·JAMA Internal Medicine·Shelly L GrayEric B Larson
Sep 9, 2015·International Urology and Nephrology·Hashim HashimLinda Cardozo
Sep 28, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jameel NazirSamuel Aballéa
Oct 21, 2015·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Nick FreemantleMarcus Drake
Feb 14, 2016·Neurourology and Urodynamics·Anthony G ViscoLinda Cardozo
Oct 30, 2016·Basic & Clinical Pharmacology & Toxicology·Karl-Erik Andersson
Apr 9, 2016·Current Bladder Dysfunction Reports·W Stuart ReynoldsRoger Dmochowski
Nov 1, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·R HamidY Hassan
Nov 1, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·R HamidD Gultyaev
Oct 30, 2016·Urology·Hugo López RamosCamila Moreno Bencardino
Nov 24, 2016·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Christopher J D WallisLesley Carr
Jan 17, 2017·International Urogynecology Journal·George AraklitisLinda Cardozo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Obstetrics & Gynecology
Elizabeth T BrownRoger Dmochowski
Indian Journal of Urology : IJU : Journal of the Urological Society of India
Ronald W Glinski, Steven Siegel
Climacteric : the Journal of the International Menopause Society
Dudley Robinson, Linda Cardozo
© 2021 Meta ULC. All rights reserved